Maa Adishakti Enterprises

Boldenone undecylenate is an injectable steroid that exhibits strong anabolic and moderately androgenic properties.The well-balanced anabolic and androgenic properties of greatly appreciated by athletes, who want to enhance their result without strong side effects. boldenone greatly stimulates hematopoiesis. Elveted levels of red blodd cells improve oxygen delivery to the muscles. This mistake this steroid attractive not only for bodybuilders,Boldenone is appreciated not only for his ability to promote lean and dense muscle growth.promote vascularity.long active life,requiring less frequentinjections and is often used a part of very long cycles.

Trenbolone Suspension is a 19-nortestosterone (Nandrolone) derivative that’s suspended in a water-based solution for injection. Aquatren is basically nandrolone with 2 added double bonds within the nucleus. It is a steroid that has high anabolic and androgenic effects of 5 times greater than testosterone. It has no estrogenic activity but does possess high progestogenic activity.

Cutmix is a blend of trenbolone acetate 75 mg, testosterone propionate 150 mg and drostanolone propionate 75 mg injection. It is a unique mixure of trenbolone, testosterone and drostanolone to loss of body weight and getting impeccably ripped.

Oxandrolone is an oral 17-alpha-alkylated steroid, modification of dihydrotestosterone. It was firstly synthesized for the treatment of debilitated HIV-infected patients, for persons with Turner syndrome, anaemia, for bones strengthening and recovery from burns. Oxandrolone does not yield to aromatization and is not estrogenic itself.  This drug is beloved by athletes, who prepares for competition in strength and endurance sports, where lean muscle without water and fat are needed

Liothyronine is a thyroidal hormone T3 which is normally produced by the thyroid gland in a ratio 4:1 when compared with T4: T3. Liothyronine is the active form of thyroxine which is composed in a basic chemical structure by a tyrosine with bound iodine.3 The exogenous liothyronine product was developed by King Pharmaceuticals and FDA approved in 1956.8